Fevipiprant
Fevipiprant (NVP-QAW039) is a potent and selective reversible antagonist of the CRTh2 receptor. It is a valuable research tool for investigating allergic diseases, such as asthma and atopic dermatitis, in both in vitro and in vivo experimental models.
Product Specifications
CAS Number
872365-14-5
Product Name Alternative
ProstaglandinReceptor, Prostaglandin Receptor, QAW 039, QAW039, QAW-039, Th2 cells, bronchial asthma, abdominal aortic aneurysm, CRTh2, Fevipiprant, NVP-QAW 039, NVP-QAW039, NVP-QAW-039, orally active, inhibit, IL-4, Inhibitor
Field of Research
Immunology & Inflammation, Metabolism Research, Pharmacology & Drug Discovery
Purity
98.00% (May vary between batches)
Solubility
10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (4.69 mM) ; DMSO:60 mg/mL (140.71 mM)
Smiles
Cc1c (CC (O) =O) c2cccnc2n1Cc1ccc (cc1C (F) (F) F) S (C) (=O) =O
Molecular Formula
C19H17F3N2O4S
Molecular Weight
426.41
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog